Botanix Pharmaceuticals Stock Price, News & Analysis (ASX:BOT)

A$0.12 +0.01 (+4.35 %)
(As of 02/23/2018 04:00 PM ET)
Previous CloseA$0.12
Today's RangeA$0.12 - A$0.12
52-Week RangeA$0.04 - A$0.21
Volume2.17 million shs
Average Volume5.81 million shs
Market Capitalization$46.40 million
P/E Ratio-12.00
Dividend YieldN/A
BetaN/A

About Botanix Pharmaceuticals (ASX:BOT)

Botanix Pharmaceuticals Limited, a clinical stage medical dermatology company, develops therapeutics for the treatment of serious skin diseases in Australia. Its products include BTX1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX1308, a transdermal gel formulation for the treatment of plaque psoriasis; BTX1204, a transdermal gel formation for the treatment of atopic dermatitis; and BTX 1701, a novel product for mild acne. The company is based in Northbridge, Australia.

Receive BOT News and Ratings via Email

Sign-up to receive the latest news and ratings for BOT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorHealthcare
SymbolASX:BOT
CUSIPN/A
Phone+61-8-94820580

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-12
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares543,110,000

Botanix Pharmaceuticals (ASX:BOT) Frequently Asked Questions

What is Botanix Pharmaceuticals' stock symbol?

Botanix Pharmaceuticals trades on the ASX under the ticker symbol "BOT."

Who are some of Botanix Pharmaceuticals' key competitors?

Who are Botanix Pharmaceuticals' key executives?

Botanix Pharmaceuticals' management team includes the folowing people:

  • Graham Griffiths, Chairman of the Board
  • William Bosch, Executive Director
  • Matthew Callahan, Executive Director
  • Simon L. Robertson, Company Secretary
  • Robert E. T. Towner, Director

What is Botanix Pharmaceuticals' stock price today?

One share of Botanix Pharmaceuticals stock can currently be purchased for approximately A$0.12.

How big of a company is Botanix Pharmaceuticals?

Botanix Pharmaceuticals has a market capitalization of $46.40 million.

How can I contact Botanix Pharmaceuticals?

Botanix Pharmaceuticals' mailing address is Ground Floor, 16 Ord St, PERTH, WAS 6005, Australia. The company can be reached via phone at +61-8-94820580.


MarketBeat Community Rating for Botanix Pharmaceuticals (BOT)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  4 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  7
MarketBeat's community ratings are surveys of what our community members think about Botanix Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Botanix Pharmaceuticals (ASX:BOT) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Botanix Pharmaceuticals (ASX:BOT)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Botanix Pharmaceuticals (ASX:BOT) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Botanix Pharmaceuticals (ASX:BOT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Botanix Pharmaceuticals (ASX BOT) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Botanix Pharmaceuticals (ASX:BOT)

Botanix Pharmaceuticals (ASX BOT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/19/2018David John GarlandDirectorSell350,000A$0.16A$56,000.00
(Data available from 1/1/2013 forward)

Headlines

Botanix Pharmaceuticals (ASX BOT) News Headlines

Source:

SEC Filings

Botanix Pharmaceuticals (ASX:BOT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Botanix Pharmaceuticals (ASX BOT) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.